BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20581017)

  • 1. Cardiovascular risk factors in primary Sjögren's syndrome: a case-control study in 624 patients.
    Pérez-De-Lis M; Akasbi M; Sisó A; Diez-Cascon P; Brito-Zerón P; Diaz-Lagares C; Ortiz J; Perez-Alvarez R; Ramos-Casals M; Coca A
    Lupus; 2010 Jul; 19(8):941-8. PubMed ID: 20581017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of serum metabolic alterations in primary Sjögren's syndrome: influence on clinical and immunological expression.
    Ramos-Casals M; Brito-Zerón P; Sisó A; Vargas A; Ros E; Bove A; Belenguer R; Plaza J; Benavent J; Font J
    J Rheumatol; 2007 Apr; 34(4):754-61. PubMed ID: 17309127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
    Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
    Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sjogren's syndrome-onset lupus patients have distinctive clinical manifestations and benign prognosis: a case-control study.
    Xu D; Tian X; Zhang W; Zhang X; Liu B; Zhang F
    Lupus; 2010 Feb; 19(2):197-200. PubMed ID: 19900977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome.
    Ramos-Casals M; Brito-Zerón P; Yagüe J; Akasbi M; Bautista R; Ruano M; Claver G; Gil V; Font J
    Rheumatology (Oxford); 2005 Jan; 44(1):89-94. PubMed ID: 15381790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjögren's syndrome.
    Ramos-Casals M; Sánchez-Tapias JM; Parés A; Forns X; Brito-Zerón P; Nardi N; Vazquez P; Vélez D; Arias I; Bové A; Plaza J; Rodés J; Font J
    J Rheumatol; 2006 Aug; 33(8):1593-9. PubMed ID: 16881116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical relevance of autoimmune neutropenia in patients with primary Sjögren's syndrome.
    Brito-Zerón P; Soria N; Muñoz S; Bové A; Akasbi M; Belenguer R; Sisó A; Ramos-Casals M
    Semin Arthritis Rheum; 2009 Apr; 38(5):389-95. PubMed ID: 18378278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis B virus infection in Sjögren's syndrome. Prevalence and clinical significance in 603 patients.
    Marcos M; Alvarez F; Brito-Zerón P; Bove A; Perez-De-Lis M; Diaz-Lagares C; Sanchez-Tapias JM; Ramos-Casals M
    Autoimmun Rev; 2009 Jun; 8(7):616-20. PubMed ID: 19393197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic relevance of neuromuscular biopsy in primary Sjögren's syndrome-related neuropathy.
    Terrier B; Lacroix C; Guillevin L; Hatron PY; Dhote R; Maillot F; Diot E; Sarrot-Reynauld F; Sordet C; Dubourg O; Meyer L; Mariette X; Gottenberg JE;
    Arthritis Rheum; 2007 Dec; 57(8):1520-9. PubMed ID: 18050172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sjögren's syndrome.
    Walker J; Gordon T; Lester S; Downie-Doyle S; McEvoy D; Pile K; Waterman S; Rischmueller M
    J Rheumatol; 2003 Nov; 30(11):2406-12. PubMed ID: 14677185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome?
    Parkin B; Chew JB; White VA; Garcia-Briones G; Chhanabhai M; Rootman J
    Ophthalmology; 2005 Nov; 112(11):2040-7. PubMed ID: 16168486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pure sensory neuropathy in primary Sjögren's syndrome. Longterm prospective followup and review of the literature.
    Font J; Ramos-Casals M; de la Red G; Pou A; Casanova A; García-Carrasco M; Cervera R; Molina JA; Valls J; Bové A; Ingelmo M; Graus F
    J Rheumatol; 2003 Jul; 30(7):1552-7. PubMed ID: 12858457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
    Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
    Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
    Szanto A; Szodoray P; Kiss E; Kapitany A; Szegedi G; Zeher M
    Hum Immunol; 2006 Nov; 67(11):924-30. PubMed ID: 17145372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary Sjögren's syndrome: clinical and immunologic study of 80 patients].
    Ramos M; Cervera R; García-Carrasco M; Miret C; Muñoz FJ; Espinosa G; Font J; Ingelmo M
    Med Clin (Barc); 1997 May; 108(17):652-7. PubMed ID: 9312582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.
    Fox RI; Dixon R; Guarrasi V; Krubel S
    Lupus; 1996 Jun; 5 Suppl 1():S31-6. PubMed ID: 8803908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticentromere antibodies identify patients with Sjögren's syndrome and autoimmune overlap syndrome.
    Salliot C; Gottenberg JE; Bengoufa D; Desmoulins F; Miceli-Richard C; Mariette X
    J Rheumatol; 2007 Nov; 34(11):2253-8. PubMed ID: 17937465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of salivary gland hypofunction in primary and secondary Sjögren's syndrome.
    Dawson LJ; Holt DJ; Higham SM; Longman LP; Field EA
    Oral Dis; 2001 Jan; 7(1):28-30. PubMed ID: 11354918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Articular manifestations in primary Sjögren's syndrome: clinical significance and prognosis of 188 patients.
    Fauchais AL; Ouattara B; Gondran G; Lalloué F; Petit D; Ly K; Lambert M; Launay D; Loustaud-Ratti V; Bezanahari H; Liozon E; Hachulla E; Jauberteau MO; Vidal E; Hatron PY
    Rheumatology (Oxford); 2010 Jun; 49(6):1164-72. PubMed ID: 20299380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjögren's syndrome correlates with increased inflammation.
    Bikker A; van Woerkom JM; Kruize AA; Wenting-van Wijk M; de Jager W; Bijlsma JW; Lafeber FP; van Roon JA
    Arthritis Rheum; 2010 Apr; 62(4):969-77. PubMed ID: 20131250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.